Ranbaxy Of India, Merck Of U.S. End Drug-Discovery Agreement
This article was originally published in PharmAsia News
Executive Summary
India's Ranbaxy Laboratories and U.S.-based Merck have ended a collaboration aimed at discovering and developing new drugs, as reported in PharmAsia News, Dec. 15